Nancy J. Leith

Array ( [id] => 17496509 [patent_doc_number] => 11285193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-29 [patent_title] => Methods and compositions for RNA-guided treatment of HIV infection [patent_app_type] => utility [patent_app_number] => 15/882207 [patent_app_country] => US [patent_app_date] => 2018-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 68 [patent_no_of_words] => 22176 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15882207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13369001 [patent_doc_number] => 20180236041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION [patent_app_type] => utility [patent_app_number] => 15/882197 [patent_app_country] => US [patent_app_date] => 2018-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22459 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15882197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12832063 [patent_doc_number] => 20180169193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION [patent_app_type] => utility [patent_app_number] => 15/879877 [patent_app_country] => US [patent_app_date] => 2018-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15879877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12729913 [patent_doc_number] => 20180135138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-17 [patent_title] => METHOD FOR EVALUATING HEALTH CONDITION AND METHOD FOR PREDICTING LONG-TERM EFFICACY OF ANTICANCER AGENT [patent_app_type] => utility [patent_app_number] => 15/870190 [patent_app_country] => US [patent_app_date] => 2018-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12461 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17741450 [patent_doc_number] => 11389495 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Combination method for treatment of cancer [patent_app_type] => utility [patent_app_number] => 15/868805 [patent_app_country] => US [patent_app_date] => 2018-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 43 [patent_no_of_words] => 17681 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15868805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13729751 [patent_doc_number] => 20180369343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM) [patent_app_type] => utility [patent_app_number] => 15/856653 [patent_app_country] => US [patent_app_date] => 2017-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15856653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13729751 [patent_doc_number] => 20180369343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM) [patent_app_type] => utility [patent_app_number] => 15/856653 [patent_app_country] => US [patent_app_date] => 2017-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15856653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13729751 [patent_doc_number] => 20180369343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM) [patent_app_type] => utility [patent_app_number] => 15/856653 [patent_app_country] => US [patent_app_date] => 2017-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15856653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13729751 [patent_doc_number] => 20180369343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM) [patent_app_type] => utility [patent_app_number] => 15/856653 [patent_app_country] => US [patent_app_date] => 2017-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15856653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19564954 [patent_doc_number] => 12139716 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-12 [patent_title] => Composition for editing a nucleic acid sequence and method using the same [patent_app_type] => utility [patent_app_number] => 16/472274 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 5160 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12886021 [patent_doc_number] => 20180187182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => DIRECTED EVOLUTION THROUGH MUTATION RATE MODULATION [patent_app_type] => utility [patent_app_number] => 15/848029 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15931751 [patent_doc_number] => 20200157509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => TARGETED INTEGRATION SITES IN CHINESE HAMSTER OVARY CELL GENOME [patent_app_type] => utility [patent_app_number] => 16/472108 [patent_app_country] => US [patent_app_date] => 2017-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12625113 [patent_doc_number] => 20180100201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-12 [patent_title] => TUMOR AND MICROENVIRONMENT GENE EXPRESSION, COMPOSITIONS OF MATTER AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/844601 [patent_app_country] => US [patent_app_date] => 2017-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 134236 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -161 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15883375 [patent_doc_number] => 10648020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-12 [patent_title] => CRISPR enzymes and systems [patent_app_type] => utility [patent_app_number] => 15/844608 [patent_app_country] => US [patent_app_date] => 2017-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 345 [patent_figures_cnt] => 388 [patent_no_of_words] => 208244 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16533515 [patent_doc_number] => 10876100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-29 [patent_title] => Crispr enzyme mutations reducing off-target effects [patent_app_type] => utility [patent_app_number] => 15/844528 [patent_app_country] => US [patent_app_date] => 2017-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 249698 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17815651 [patent_doc_number] => 11421250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => CRISPR enzymes and systems [patent_app_type] => utility [patent_app_number] => 15/844530 [patent_app_country] => US [patent_app_date] => 2017-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 348 [patent_figures_cnt] => 416 [patent_no_of_words] => 125916 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13537233 [patent_doc_number] => 20180320163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS [patent_app_type] => utility [patent_app_number] => 15/842073 [patent_app_country] => US [patent_app_date] => 2017-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 201001 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -75 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12707737 [patent_doc_number] => 20180127745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => CELL SORTING [patent_app_type] => utility [patent_app_number] => 15/842315 [patent_app_country] => US [patent_app_date] => 2017-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18202548 [patent_doc_number] => 11584931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Methods and compositions for generating a deletion library and for identifying a defective interfering particle (DIP) [patent_app_type] => utility [patent_app_number] => 16/467233 [patent_app_country] => US [patent_app_date] => 2017-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 50 [patent_no_of_words] => 37022 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13508323 [patent_doc_number] => 20180305704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-25 [patent_title] => CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION [patent_app_type] => utility [patent_app_number] => 15/838064 [patent_app_country] => US [patent_app_date] => 2017-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15838064 [rel_patent_id] =>[rel_patent_doc_number] =>)